Proactiveinvestors Australia Avacta Group PLC https://www.proactiveinvestors.com.au Proactiveinvestors Australia Avacta Group PLC RSS feed en Tue, 12 Nov 2019 22:42:39 +1100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Avacta Group heading into 'crucial year' for its cancer therapeutics programmes https://www.proactiveinvestors.com.au/companies/news/905413/avacta-group-heading-into--crucial-year--for-its-cancer-therapeutics-programmes-905413.html Wed, 23 Oct 2019 07:11:00 +1100 https://www.proactiveinvestors.com.au/companies/news/905413/avacta-group-heading-into--crucial-year--for-its-cancer-therapeutics-programmes-905413.html Avacta - Transformational new project https://www.proactiveinvestors.com.au/companies/news/905344/avacta---transformational-new-project-905344.html Tue, 22 Oct 2019 12:17:00 +1100 https://www.proactiveinvestors.com.au/companies/news/905344/avacta---transformational-new-project-905344.html Avacta Group PLC boss sees a huge opportunity with new version of cancer treatment https://www.proactiveinvestors.com.au/companies/news/905244/avacta-group-plc-boss-sees-a-huge-opportunity-with-new-version-of-cancer-treatment-905244.html Mon, 21 Oct 2019 11:44:00 +1100 https://www.proactiveinvestors.com.au/companies/news/905244/avacta-group-plc-boss-sees-a-huge-opportunity-with-new-version-of-cancer-treatment-905244.html Avacta progresses with the development of its Affimer candidate https://www.proactiveinvestors.com.au/companies/news/219597/avacta-progresses-with-the-development-of-its-affimer-candidate-219597.html Mon, 21 Oct 2019 06:45:00 +1100 https://www.proactiveinvestors.com.au/companies/news/219597/avacta-progresses-with-the-development-of-its-affimer-candidate-219597.html Avacta raises £9mln as its moves towards first clinical trial https://www.proactiveinvestors.com.au/companies/news/905153/avacta-raises-9mln-as-its-moves-towards-first-clinical-trial-905153.html Fri, 18 Oct 2019 13:08:00 +1100 https://www.proactiveinvestors.com.au/companies/news/905153/avacta-raises-9mln-as-its-moves-towards-first-clinical-trial-905153.html XP Power sparks as orders rise despite semiconductor slowdown https://www.proactiveinvestors.com.au/companies/news/904561/xp-power-sparks-as-orders-rise-despite-semiconductor-slowdown-904561.html Thu, 10 Oct 2019 14:10:00 +1100 https://www.proactiveinvestors.com.au/companies/news/904561/xp-power-sparks-as-orders-rise-despite-semiconductor-slowdown-904561.html Avacta inks collaboration with ADC Therapeutics SA https://www.proactiveinvestors.com.au/companies/news/904555/avacta-inks-collaboration-with-adc-therapeutics-sa-904555.html Thu, 10 Oct 2019 07:18:00 +1100 https://www.proactiveinvestors.com.au/companies/news/904555/avacta-inks-collaboration-with-adc-therapeutics-sa-904555.html Avacta teams up with Selexis to develop Chinese hamster ovary cell line https://www.proactiveinvestors.com.au/companies/news/222477/avacta-teams-up-with-selexis-to-develop-chinese-hamster-ovary-cell-line-222477.html Thu, 20 Jun 2019 06:55:00 +1000 https://www.proactiveinvestors.com.au/companies/news/222477/avacta-teams-up-with-selexis-to-develop-chinese-hamster-ovary-cell-line-222477.html Avacta's Alastair Smith updates on selection of cancer candidate to take into clinic https://www.proactiveinvestors.com.au/companies/news/313762/avacta-s-alastair-smith-updates-on-selection-of-cancer-candidate-to-take-into-clinic-13762.html Mon, 17 Jun 2019 13:20:00 +1000 https://www.proactiveinvestors.com.au/companies/news/313762/avacta-s-alastair-smith-updates-on-selection-of-cancer-candidate-to-take-into-clinic-13762.html Avacta selects drug candidate for phase I trial https://www.proactiveinvestors.com.au/companies/news/221768/avacta-selects-drug-candidate-for-phase-i-trial-221768.html Mon, 10 Jun 2019 10:42:00 +1000 https://www.proactiveinvestors.com.au/companies/news/221768/avacta-selects-drug-candidate-for-phase-i-trial-221768.html Avacta plans for exciting cancer immunotherapy https://www.proactiveinvestors.com.au/companies/news/221354/avacta-plans-for-exciting-cancer-immunotherapy-221354.html Mon, 03 Jun 2019 10:21:00 +1000 https://www.proactiveinvestors.com.au/companies/news/221354/avacta-plans-for-exciting-cancer-immunotherapy-221354.html Avacta firmly focused on first-in-human Affimer therapeutic trial https://www.proactiveinvestors.com.au/companies/news/312970/avacta-firmly-focused-on-first-in-human-affimer-therapeutic-trial-12970.html Thu, 11 Apr 2019 13:53:00 +1000 https://www.proactiveinvestors.com.au/companies/news/312970/avacta-firmly-focused-on-first-in-human-affimer-therapeutic-trial-12970.html Avacta Plc's therapeutics business 'has huge amount of potential' - analyst Ed Stacey https://www.proactiveinvestors.com.au/companies/news/330173/avacta-plc-s-therapeutics-business-has-huge-amount-of-potential-analyst-ed-stacey-0173.html Tue, 09 Apr 2019 13:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/330173/avacta-plc-s-therapeutics-business-has-huge-amount-of-potential-analyst-ed-stacey-0173.html Avacta well-cashed and on track to begin clinical trial of first Affimer therapeutic next year https://www.proactiveinvestors.com.au/companies/news/218211/avacta-well-cashed-and-on-track-to-begin-clinical-trial-of-first-affimer-therapeutic-next-year-218211.html Tue, 09 Apr 2019 10:40:00 +1000 https://www.proactiveinvestors.com.au/companies/news/218211/avacta-well-cashed-and-on-track-to-begin-clinical-trial-of-first-affimer-therapeutic-next-year-218211.html Avacta Plc's therapeutics business 'has huge amount of potential' - analyst Ed Stacey https://www.proactiveinvestors.com.au/companies/news/312927/avacta-plc-s-therapeutics-business--has-huge-amount-of-potential----analyst-ed-stacey-12927.html Tue, 09 Apr 2019 10:24:00 +1000 https://www.proactiveinvestors.com.au/companies/news/312927/avacta-plc-s-therapeutics-business--has-huge-amount-of-potential----analyst-ed-stacey-12927.html Avacta - interim results confirm progress https://www.proactiveinvestors.com.au/companies/news/430666/avacta---interim-results-confirm-progress-430666.html Tue, 09 Apr 2019 08:01:00 +1000 https://www.proactiveinvestors.com.au/companies/news/430666/avacta---interim-results-confirm-progress-430666.html Avacta says partner Moderna takes collaboration to next level https://www.proactiveinvestors.com.au/companies/news/213871/avacta-says-partner-moderna-takes-collaboration-to-next-level-213871.html Mon, 04 Feb 2019 15:15:00 +1100 https://www.proactiveinvestors.com.au/companies/news/213871/avacta-says-partner-moderna-takes-collaboration-to-next-level-213871.html Avacta's Alastair Smith encouraged by significant progress and share price momentum https://www.proactiveinvestors.com.au/companies/news/311972/avacta-s-alastair-smith-encouraged-by-significant-progress-and-share-price-momentum-11972.html Thu, 24 Jan 2019 10:17:00 +1100 https://www.proactiveinvestors.com.au/companies/news/311972/avacta-s-alastair-smith-encouraged-by-significant-progress-and-share-price-momentum-11972.html Avacta Group trading in line in "year of very significant progress" https://www.proactiveinvestors.com.au/companies/news/212976/avacta-group-trading-in-line-in--year-of-very-significant-progress--212976.html Mon, 21 Jan 2019 12:56:00 +1100 https://www.proactiveinvestors.com.au/companies/news/212976/avacta-group-trading-in-line-in--year-of-very-significant-progress--212976.html Avacta appoints industry heavyweight as chief medical officer https://www.proactiveinvestors.com.au/companies/news/211031/avacta-appoints-industry-heavyweight-as-chief-medical-officer-211031.html Wed, 12 Dec 2018 12:20:00 +1100 https://www.proactiveinvestors.com.au/companies/news/211031/avacta-appoints-industry-heavyweight-as-chief-medical-officer-211031.html Avacta soars after signing partnership deal with Korea's LG Group https://www.proactiveinvestors.com.au/companies/news/210844/avacta-soars-after-signing-partnership-deal-with-korea-s-lg-group-210844.html Mon, 10 Dec 2018 14:50:00 +1100 https://www.proactiveinvestors.com.au/companies/news/210844/avacta-soars-after-signing-partnership-deal-with-korea-s-lg-group-210844.html Avacta Group PLC signs first significant pharmaceutical licensing deal https://www.proactiveinvestors.com.au/companies/news/311542/avacta-group-plc-signs-first-significant-pharmaceutical-licensing-deal Mon, 10 Dec 2018 08:05:00 +1100 https://www.proactiveinvestors.com.au/companies/news/311542/avacta-group-plc-signs-first-significant-pharmaceutical-licensing-deal Avacta’s Affimer tech gains traction as it clinches deal with “very high quality partner” https://www.proactiveinvestors.com.au/companies/news/210221/avactas-affimer-tech-gains-traction-as-it-clinches-deal-with-very-high-quality-partner-210221.html Thu, 29 Nov 2018 08:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/210221/avactas-affimer-tech-gains-traction-as-it-clinches-deal-with-very-high-quality-partner-210221.html Avacta Group signs licensing deal with New England Biolabs (NEB) https://www.proactiveinvestors.com.au/companies/news/310817/avacta-group-signs-licensing-deal-with-new-england-biolabs-neb-10817.html Thu, 11 Oct 2018 12:26:00 +1100 https://www.proactiveinvestors.com.au/companies/news/310817/avacta-group-signs-licensing-deal-with-new-england-biolabs-neb-10817.html Avacta’s CTO to present Affimer data at Biomarkers and Precision Medicine Congress https://www.proactiveinvestors.com.au/companies/news/206861/avactas-cto-to-present-affimer-data-at-biomarkers-and-precision-medicine-congress-206861.html Thu, 11 Oct 2018 06:45:00 +1100 https://www.proactiveinvestors.com.au/companies/news/206861/avactas-cto-to-present-affimer-data-at-biomarkers-and-precision-medicine-congress-206861.html Avacta rises as it secures licensing deal with New England Biolabs for Affimer technology https://www.proactiveinvestors.com.au/companies/news/206741/avacta-rises-as-it-secures-licensing-deal-with-new-england-biolabs-for-affimer-technology-206741.html Wed, 10 Oct 2018 10:48:00 +1100 https://www.proactiveinvestors.com.au/companies/news/206741/avacta-rises-as-it-secures-licensing-deal-with-new-england-biolabs-for-affimer-technology-206741.html Avacta Group CEO Alastair Smith confident of licensing deals this year https://www.proactiveinvestors.com.au/companies/news/310734/avacta-group-ceo-alastair-smith-confident-of-licensing-deals-this-year-10734.html Thu, 04 Oct 2018 13:11:00 +1000 https://www.proactiveinvestors.com.au/companies/news/310734/avacta-group-ceo-alastair-smith-confident-of-licensing-deals-this-year-10734.html Avacta Plc 'making significant progress towards commercialising Affimer platform' https://www.proactiveinvestors.com.au/companies/news/330139/avacta-plc-making-significant-progress-towards-commercialising-affimer-platform--0139.html Thu, 04 Oct 2018 10:56:00 +1000 https://www.proactiveinvestors.com.au/companies/news/330139/avacta-plc-making-significant-progress-towards-commercialising-affimer-platform--0139.html Avacta Plc 'making significant progress towards commercialising Affimer platform' https://www.proactiveinvestors.com.au/companies/news/310731/avacta-plc-making-significant-progress-towards-commercialising-affimer-platform--10731.html Thu, 04 Oct 2018 10:41:00 +1000 https://www.proactiveinvestors.com.au/companies/news/310731/avacta-plc-making-significant-progress-towards-commercialising-affimer-platform--10731.html Avacta making “significant progress” with Affimer partnering discussions https://www.proactiveinvestors.com.au/companies/news/206164/avacta-making-significant-progress-with-affimer-partnering-discussions-206164.html Tue, 02 Oct 2018 07:01:00 +1000 https://www.proactiveinvestors.com.au/companies/news/206164/avacta-making-significant-progress-with-affimer-partnering-discussions-206164.html Avacta Group's Bach BioSciences deal 'an exciting step' https://www.proactiveinvestors.com.au/companies/news/330130/avacta-group-s-bach-biosciences-deal-an-exciting-step--0130.html Tue, 31 Jul 2018 12:21:00 +1000 https://www.proactiveinvestors.com.au/companies/news/330130/avacta-group-s-bach-biosciences-deal-an-exciting-step--0130.html Avacta Group's Bach BioSciences deal 'an exciting step' - Capital Network analyst https://www.proactiveinvestors.com.au/companies/news/309995/avacta-group-s-bach-biosciences-deal-an-exciting-step-capital-network-analyst-9995.html Tue, 31 Jul 2018 11:41:00 +1000 https://www.proactiveinvestors.com.au/companies/news/309995/avacta-group-s-bach-biosciences-deal-an-exciting-step-capital-network-analyst-9995.html Avacta taps market as it eyes further licensing deals this year https://www.proactiveinvestors.com.au/companies/news/201839/avacta-taps-market-as-it-eyes-further-licensing-deals-this-year-201839.html Mon, 30 Jul 2018 17:15:00 +1000 https://www.proactiveinvestors.com.au/companies/news/201839/avacta-taps-market-as-it-eyes-further-licensing-deals-this-year-201839.html Avacta Group - Exciting partnership with Bach BioSciences https://www.proactiveinvestors.com.au/companies/news/430616/avacta-group---exciting-partnership-with-bach-biosciences-430616.html Mon, 30 Jul 2018 07:34:00 +1000 https://www.proactiveinvestors.com.au/companies/news/430616/avacta-group---exciting-partnership-with-bach-biosciences-430616.html Avacta Group PLC agrees major co-development partnership with US business https://www.proactiveinvestors.com.au/companies/news/309943/avacta-group-plc-agrees-major-co-development-partnership-with-us-business-9943.html Wed, 25 Jul 2018 11:20:00 +1000 https://www.proactiveinvestors.com.au/companies/news/309943/avacta-group-plc-agrees-major-co-development-partnership-with-us-business-9943.html Avacta shares jump as much as 60% after it inks co-development deal with US innovator https://www.proactiveinvestors.com.au/companies/news/201406/avacta-shares-jump-as-much-as-60-after-it-inks-co-development-deal-with-us-innovator-201406.html Tue, 24 Jul 2018 11:16:00 +1000 https://www.proactiveinvestors.com.au/companies/news/201406/avacta-shares-jump-as-much-as-60-after-it-inks-co-development-deal-with-us-innovator-201406.html Avacta Group Plc focused on securing third-party deals for both sides of the business https://www.proactiveinvestors.com.au/companies/news/309584/avacta-group-plc-focused-on-securing-third-party-deals-for-both-sides-of-the-business-9584.html Thu, 14 Jun 2018 14:54:00 +1000 https://www.proactiveinvestors.com.au/companies/news/309584/avacta-group-plc-focused-on-securing-third-party-deals-for-both-sides-of-the-business-9584.html Avacta Group appoints Immunocore’s Eliot Forster as non-executive chairman https://www.proactiveinvestors.com.au/companies/news/198580/avacta-group-appoints-immunocores-eliot-forster-as-non-executive-chairman-198580.html Mon, 11 Jun 2018 06:59:00 +1000 https://www.proactiveinvestors.com.au/companies/news/198580/avacta-group-appoints-immunocores-eliot-forster-as-non-executive-chairman-198580.html Avacta hails encouraging results of tie-up with Finnish firm, shares gain https://www.proactiveinvestors.com.au/companies/news/197436/avacta-hails-encouraging-results-of-tie-up-with-finnish-firm-shares-gain-197436.html Tue, 22 May 2018 09:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/197436/avacta-hails-encouraging-results-of-tie-up-with-finnish-firm-shares-gain-197436.html Riccardo Lowi discusses Avacta https://www.proactiveinvestors.com.au/companies/news/330119/riccardo-lowi-discusses-avacta-0119.html Fri, 04 May 2018 10:44:00 +1000 https://www.proactiveinvestors.com.au/companies/news/330119/riccardo-lowi-discusses-avacta-0119.html Avacta on track to deliver pre-clinical milestones this year https://www.proactiveinvestors.com.au/companies/news/195019/avacta-on-track-to-deliver-pre-clinical-milestones-this-year-195019.html Tue, 01 May 2018 07:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/195019/avacta-on-track-to-deliver-pre-clinical-milestones-this-year-195019.html Avacta Group Plc making 'excellent progress' on lead programmes https://www.proactiveinvestors.com.au/companies/news/309070/avacta-group-plc-making-excellent-progress-on-lead-programmes-9070.html Mon, 16 Apr 2018 14:22:00 +1000 https://www.proactiveinvestors.com.au/companies/news/309070/avacta-group-plc-making-excellent-progress-on-lead-programmes-9070.html Avacta Group - Rapid Progress of Immuno-oncology Programs https://www.proactiveinvestors.com.au/companies/news/430600/avacta-group---rapid-progress-of-immuno-oncology-programs-430600.html Mon, 16 Apr 2018 08:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/430600/avacta-group---rapid-progress-of-immuno-oncology-programs-430600.html Avacta Group looks to Asia for partner as it plans first Affimer clinical trial https://www.proactiveinvestors.com.au/companies/news/191363/avacta-group-looks-to-asia-for-partner-as-it-plans-first-affimer-clinical-trial-191363.html Thu, 08 Feb 2018 08:18:00 +1100 https://www.proactiveinvestors.com.au/companies/news/191363/avacta-group-looks-to-asia-for-partner-as-it-plans-first-affimer-clinical-trial-191363.html Avacta Group Plc - On track and undervalued https://www.proactiveinvestors.com.au/companies/news/430579/avacta-group-plc---on-track-and-undervalued-430579.html Wed, 24 Jan 2018 10:18:00 +1100 https://www.proactiveinvestors.com.au/companies/news/430579/avacta-group-plc---on-track-and-undervalued-430579.html Avacta enters significant partnership with OncoSec Medical https://www.proactiveinvestors.com.au/companies/news/308645/avacta-enters-significant-partnership-with-oncosec-medical-8645.html Mon, 22 Jan 2018 10:45:00 +1100 https://www.proactiveinvestors.com.au/companies/news/308645/avacta-enters-significant-partnership-with-oncosec-medical-8645.html Interest in Avacta’s Affimer technology continues to grow as biotech unveils latest research partnership https://www.proactiveinvestors.com.au/companies/news/190354/interest-in-avactas-affimer-technology-continues-to-grow-as-biotech-unveils-latest-research-partnership-190354.html Mon, 22 Jan 2018 09:55:00 +1100 https://www.proactiveinvestors.com.au/companies/news/190354/interest-in-avactas-affimer-technology-continues-to-grow-as-biotech-unveils-latest-research-partnership-190354.html Avacta boss praises “strong” progress made in first half https://www.proactiveinvestors.com.au/companies/news/190239/avacta-boss-praises-strong-progress-made-in-first-half-190239.html Thu, 18 Jan 2018 11:35:00 +1100 https://www.proactiveinvestors.com.au/companies/news/190239/avacta-boss-praises-strong-progress-made-in-first-half-190239.html Avacta agrees licensing deal with antibody drug conjugates specialist Glythera https://www.proactiveinvestors.com.au/companies/news/190023/avacta-agrees-licensing-deal-with-antibody-drug-conjugates-specialist-glythera-190023.html Mon, 15 Jan 2018 10:51:00 +1100 https://www.proactiveinvestors.com.au/companies/news/190023/avacta-agrees-licensing-deal-with-antibody-drug-conjugates-specialist-glythera-190023.html Avacta partner to present data on breakthrough technology at Barcelona conference https://www.proactiveinvestors.com.au/companies/news/187280/avacta-partner-to-present-data-on-breakthrough-technology-at-barcelona-conference-187280.html Wed, 15 Nov 2017 08:01:00 +1100 https://www.proactiveinvestors.com.au/companies/news/187280/avacta-partner-to-present-data-on-breakthrough-technology-at-barcelona-conference-187280.html Interest in Affimer technology at record levels, which bodes well for Avacta https://www.proactiveinvestors.com.au/companies/news/186075/interest-in-affimer-technology-at-record-levels-which-bodes-well-for-avacta-186075.html Tue, 24 Oct 2017 06:32:00 +1100 https://www.proactiveinvestors.com.au/companies/news/186075/interest-in-affimer-technology-at-record-levels-which-bodes-well-for-avacta-186075.html Avacta Group Plc - Elevator Pitch https://www.proactiveinvestors.com.au/companies/news/308206/avacta-group-plc-elevator-pitch-8206.html Mon, 09 Oct 2017 08:23:00 +1100 https://www.proactiveinvestors.com.au/companies/news/308206/avacta-group-plc-elevator-pitch-8206.html Patient heal thyself - Avacta teams up with Finnish biotech firm to develop system that allows body to create its own drugs https://www.proactiveinvestors.com.au/companies/news/185100/patient-heal-thyself-avacta-teams-up-with-finnish-biotech-firm-to-develop-system-that-allows-body-to-create-its-own-drugs-185100.html Thu, 05 Oct 2017 11:15:00 +1100 https://www.proactiveinvestors.com.au/companies/news/185100/patient-heal-thyself-avacta-teams-up-with-finnish-biotech-firm-to-develop-system-that-allows-body-to-create-its-own-drugs-185100.html Avacta boss Alastair Smith anticipating 2018 to be a very significant year https://www.proactiveinvestors.com.au/companies/news/308186/avacta-boss-alastair-smith-anticipating-2018-to-be-a-very-significant-year-8186.html Wed, 04 Oct 2017 08:46:00 +1100 https://www.proactiveinvestors.com.au/companies/news/308186/avacta-boss-alastair-smith-anticipating-2018-to-be-a-very-significant-year-8186.html Avacta Group - Capital Network: Preliminary Results https://www.proactiveinvestors.com.au/companies/news/430540/avacta-group---capital-network-preliminary-results-430540.html Wed, 04 Oct 2017 08:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/430540/avacta-group---capital-network-preliminary-results-430540.html Pioneering Avacta making progress on all fronts https://www.proactiveinvestors.com.au/companies/news/185024/pioneering-avacta-making-progress-on-all-fronts-185024.html Wed, 04 Oct 2017 07:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/185024/pioneering-avacta-making-progress-on-all-fronts-185024.html Avacta ramps up US offensive with a the appointment of three-strong business development team https://www.proactiveinvestors.com.au/companies/news/184893/avacta-ramps-up-us-offensive-with-a-the-appointment-of-three-strong-business-development-team-184893.html Mon, 02 Oct 2017 06:54:00 +1100 https://www.proactiveinvestors.com.au/companies/news/184893/avacta-ramps-up-us-offensive-with-a-the-appointment-of-three-strong-business-development-team-184893.html Avacta building on 'significant' commercial momentum for Affimer technology https://www.proactiveinvestors.com.au/companies/news/307897/avacta-building-on-significant-commercial-momentum-for-affimer-technology-7897.html Mon, 07 Aug 2017 15:10:00 +1000 https://www.proactiveinvestors.com.au/companies/news/307897/avacta-building-on-significant-commercial-momentum-for-affimer-technology-7897.html Avacta Group “significant technical and commercial” headway https://www.proactiveinvestors.com.au/companies/news/182038/avacta-group-significant-technical-and-commercial-headway-182038.html Mon, 07 Aug 2017 06:37:00 +1000 https://www.proactiveinvestors.com.au/companies/news/182038/avacta-group-significant-technical-and-commercial-headway-182038.html Avacta says two leading US biotechs are using the company's technology https://www.proactiveinvestors.com.au/companies/news/178117/avacta-says-two-leading-us-biotechs-are-using-the-company-s-technology-178117.html Mon, 22 May 2017 07:26:00 +1000 https://www.proactiveinvestors.com.au/companies/news/178117/avacta-says-two-leading-us-biotechs-are-using-the-company-s-technology-178117.html Avacta awarded patent for Affirmer technology in China https://www.proactiveinvestors.com.au/companies/news/177580/avacta-awarded-patent-for-affirmer-technology-in-china-177580.html Wed, 10 May 2017 08:39:00 +1000 https://www.proactiveinvestors.com.au/companies/news/177580/avacta-awarded-patent-for-affirmer-technology-in-china-177580.html Capital Network's Riccardo Lowi on Avacta Group Plc https://www.proactiveinvestors.com.au/companies/news/330050/capital-network-s-riccardo-lowi-on-avacta-group-plc-0050.html Tue, 09 May 2017 09:12:00 +1000 https://www.proactiveinvestors.com.au/companies/news/330050/capital-network-s-riccardo-lowi-on-avacta-group-plc-0050.html Avacta CEO Dr Alastair Smith 'encouraged' by first commercial Affimer deal https://www.proactiveinvestors.com.au/companies/news/307332/avacta-ceo-dr-alastair-smith-encouraged-by-first-commercial-affimer-deal-7332.html Tue, 25 Apr 2017 09:46:00 +1000 https://www.proactiveinvestors.com.au/companies/news/307332/avacta-ceo-dr-alastair-smith-encouraged-by-first-commercial-affimer-deal-7332.html Avacta Group says it is at "value inflection point" as customer trial results in deal https://www.proactiveinvestors.com.au/companies/news/176770/avacta-group-says-it-is-at-value-inflection-point-as-customer-trial-results-in-deal-176770.html Mon, 24 Apr 2017 10:58:00 +1000 https://www.proactiveinvestors.com.au/companies/news/176770/avacta-group-says-it-is-at-value-inflection-point-as-customer-trial-results-in-deal-176770.html Capital Network’s Riccardo Lowi talks over Avacta’s recent immunogenicity data https://www.proactiveinvestors.com.au/companies/news/330042/capital-networks-riccardo-lowi-talks-over-avactas-recent-immunogenicity-data-0042.html Mon, 10 Apr 2017 09:09:00 +1000 https://www.proactiveinvestors.com.au/companies/news/330042/capital-networks-riccardo-lowi-talks-over-avactas-recent-immunogenicity-data-0042.html Avacta Group - Capital Network: Milestone Immunogenicity Data https://www.proactiveinvestors.com.au/companies/news/430493/avacta-group---capital-network-milestone-immunogenicity-data-430493.html Tue, 04 Apr 2017 14:20:00 +1000 https://www.proactiveinvestors.com.au/companies/news/430493/avacta-group---capital-network-milestone-immunogenicity-data-430493.html Avacta Group boss talks through 'excellent' Affimer study results https://www.proactiveinvestors.com.au/companies/news/307223/avacta-group-boss-talks-through-excellent-affimer-study-results-7223.html Tue, 04 Apr 2017 10:11:00 +1000 https://www.proactiveinvestors.com.au/companies/news/307223/avacta-group-boss-talks-through-excellent-affimer-study-results-7223.html Innovative Avacta building the framework for success https://www.proactiveinvestors.com.au/companies/news/175848/innovative-avacta-building-the-framework-for-success-175848.html Mon, 03 Apr 2017 11:54:00 +1000 https://www.proactiveinvestors.com.au/companies/news/175848/innovative-avacta-building-the-framework-for-success-175848.html Avacta Group PLC technology at an "inflexion point" following "excellent" results from latest study https://www.proactiveinvestors.com.au/companies/news/175814/avacta-group-plc-technology-at-an-inflexion-point-following-excellent-results-from-latest-study-175814.html Mon, 03 Apr 2017 06:42:00 +1000 https://www.proactiveinvestors.com.au/companies/news/175814/avacta-group-plc-technology-at-an-inflexion-point-following-excellent-results-from-latest-study-175814.html Finncap highlights upcoming immunogenicity data for Avacta's Affimer protein scaffold as another key "milestone“ https://www.proactiveinvestors.com.au/companies/news/174841/finncap-highlights-upcoming-immunogenicity-data-for-avacta-s-affimer-protein-scaffold-as-another-key-milestone-174841.html Wed, 15 Mar 2017 12:37:00 +1100 https://www.proactiveinvestors.com.au/companies/news/174841/finncap-highlights-upcoming-immunogenicity-data-for-avacta-s-affimer-protein-scaffold-as-another-key-milestone-174841.html Capital Network analyst thinks biotech firm Avacta "significantly undervalued" https://www.proactiveinvestors.com.au/companies/news/174560/capital-network-analyst-thinks-biotech-firm-avacta-significantly-undervalued--174560.html Thu, 09 Mar 2017 15:29:00 +1100 https://www.proactiveinvestors.com.au/companies/news/174560/capital-network-analyst-thinks-biotech-firm-avacta-significantly-undervalued--174560.html Avacta Group - Capital Network: Initiation of Coverage https://www.proactiveinvestors.com.au/companies/news/430478/avacta-group---capital-network-initiation-of-coverage-430478.html Wed, 08 Mar 2017 10:40:00 +1100 https://www.proactiveinvestors.com.au/companies/news/430478/avacta-group---capital-network-initiation-of-coverage-430478.html 2016 'a really excellent year of progress' says Avacta CEO https://www.proactiveinvestors.com.au/companies/news/306771/2016-a-really-excellent-year-of-progress-says-avacta-ceo-6771.html Mon, 23 Jan 2017 09:32:00 +1100 https://www.proactiveinvestors.com.au/companies/news/306771/2016-a-really-excellent-year-of-progress-says-avacta-ceo-6771.html Avacta Group expects first licensing deal in 2017 https://www.proactiveinvestors.com.au/companies/news/171934/avacta-group-expects-first-licensing-deal-in-2017-171934.html Fri, 20 Jan 2017 14:44:00 +1100 https://www.proactiveinvestors.com.au/companies/news/171934/avacta-group-expects-first-licensing-deal-in-2017-171934.html City broker expecting big things from Avacta https://www.proactiveinvestors.com.au/companies/news/168332/city-broker-expecting-big-things-from-avacta-168332.html Tue, 01 Nov 2016 10:45:00 +1100 https://www.proactiveinvestors.com.au/companies/news/168332/city-broker-expecting-big-things-from-avacta-168332.html Avacta and the antibody alternative with "endless" applications https://www.proactiveinvestors.com.au/companies/news/129506/avacta-and-the-antibody-alternative-with-endless-applications-129506.html Fri, 19 Aug 2016 08:05:00 +1000 https://www.proactiveinvestors.com.au/companies/news/129506/avacta-and-the-antibody-alternative-with-endless-applications-129506.html Avacta boss explains potential of its Affimer technology https://www.proactiveinvestors.com.au/companies/news/305396/avacta-boss-explains-potential-of-its-affimer-technology-5396.html Mon, 15 Aug 2016 06:29:00 +1000 https://www.proactiveinvestors.com.au/companies/news/305396/avacta-boss-explains-potential-of-its-affimer-technology-5396.html Avacta shares up after "transformational" deal with US biotech firm Moderna https://www.proactiveinvestors.com.au/companies/news/106882/avacta-shares-up-after-transformational-deal-with-us-biotech-firm-moderna-106882.html Mon, 18 May 2015 12:20:00 +1000 https://www.proactiveinvestors.com.au/companies/news/106882/avacta-shares-up-after-transformational-deal-with-us-biotech-firm-moderna-106882.html Avacta Group hails Optim sales as announces trading update https://www.proactiveinvestors.com.au/companies/news/26566/avacta-group-hails-optim-sales-as-announces-trading-update-31701.html Tue, 09 Aug 2011 08:20:00 +1000 https://www.proactiveinvestors.com.au/companies/news/26566/avacta-group-hails-optim-sales-as-announces-trading-update-31701.html Avacta Group: Optim sales growth and Pall Corp tie-up puts group in ‘higher league’ https://www.proactiveinvestors.com.au/companies/news/21914/avacta-group-optim-sales-growth-and-pall-corp-tie-up-puts-group-in-higher-league--26129.html On Friday the AIM-listed bio-technology group told investors that it has seen growing sales momentum in recent months, particularly for its Optim biophysical analysis product. Indeed it has been an interesting stock to watch in the past three months. The shares have almost tripled in value, it has signed up a blue-chip partner and its revenues are growing. XCap Securities Tim Freeborn reckons the stock could be worth 2.5 pence a share as the new deal takes the firm into a ‘higher league”.

 

]]>
Mon, 07 Mar 2011 10:20:00 +1100 https://www.proactiveinvestors.com.au/companies/news/21914/avacta-group-optim-sales-growth-and-pall-corp-tie-up-puts-group-in-higher-league--26129.html
Avacta says it made good commercial progress in tough economic climate https://www.proactiveinvestors.com.au/companies/news/21872/avacta-says-it-made-good-commercial-progress-in-tough-economic-climate-26088.html Fri, 04 Mar 2011 07:45:00 +1100 https://www.proactiveinvestors.com.au/companies/news/21872/avacta-says-it-made-good-commercial-progress-in-tough-economic-climate-26088.html Avacta on the brink of becoming revenue-generating https://www.proactiveinvestors.com.au/companies/news/3795/avacta-on-the-brink-of-becoming-revenue-generating-5337.html Thu, 23 Apr 2009 12:59:00 +1000 https://www.proactiveinvestors.com.au/companies/news/3795/avacta-on-the-brink-of-becoming-revenue-generating-5337.html Avacta Group acquires YorkTest Vet Services for £0.825 million https://www.proactiveinvestors.com.au/companies/news/2989/avacta-group-acquires-yorktest-vet-services-for-0825-million-4336.html Mon, 09 Feb 2009 11:21:00 +1100 https://www.proactiveinvestors.com.au/companies/news/2989/avacta-group-acquires-yorktest-vet-services-for-0825-million-4336.html